Free Trial
NYSEARCA:IDNA

iShares Genomics Immunology and Healthcare ETF (IDNA) Price, Holdings, & News

iShares Genomics Immunology and Healthcare ETF logo
$20.64 +0.13 (+0.63%)
As of 04:10 PM Eastern

About iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)

Key Stats

Today's Range
$20.40
$21.00
50-Day Range
$19.13
$21.50
52-Week Range
$17.26
$25.80
Volume
19,526 shs
Average Volume
31,231 shs
Market Capitalization
$106.30 million
Assets Under Management
$105.83 million
Dividend Yield
1.26%
Net Expense Ratio
0.47%
Aggregate Rating
Moderate Buy

ETF Overview

iShares Genomics Immunology and Healthcare ETF Expenses

TypeIDNATheme ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.47%0.57%0.56%0.51%0.53%
Other Expenses0.00%0.58%0.56%0.59%0.56%
Total Expense0.47%0.74%0.76%0.74%0.73%
Fee Waiver0.00%-0.76%-0.66%-0.71%-0.63%
Net Expense0.47%0.60%0.63%0.58%0.60%
Receive IDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Genomics Immunology and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter.

IDNA ETF News Headlines

3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) (IUHC.L)
iDNA Genomics Public Ltd
See More Headlines

IDNA ETF - Frequently Asked Questions

iShares Genomics Immunology and Healthcare ETF's stock was trading at $22.63 at the beginning of 2025. Since then, IDNA shares have decreased by 8.8% and is now trading at $20.64.
View the best growth stocks for 2025 here
.

Shares of IDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Genomics Immunology and Healthcare ETF investors own include iShares Micro-Cap ETF (IWC), The RMR Group (RMR), Waste Connections (WCN), DiamondRock Hospitality (DRH), AU Optronics (AUOTY), American Water Works (AWK) and Triple Flag Precious Metals (TFPM).

Fund Details

Issuer
iShares
Fund Name
iShares Genomics Immunology and Healthcare ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:IDNA
Inception Date
6/11/2019
Fund Manager
Jennifer Hsui, Greg Savage, Paul Whitehead
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
NYSE FactSet Global Genomics and Immuno Biopharma Index
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
61

Fund Statistics

Assets Under Management
$105.83 million
Average Daily Volume
$0.00
Discount/Premium
-0.04%

Administrator, Advisor and Custodian

Administrator
State Street Bank and Trust Company
Advisor
BlackRock Fund Advisors
Custodian
State Street Bank and Trust Company
Distributor
BlackRock Investments, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
Optionable
Options Volume
1
Put Options
2
Call Options
1
Short Interest
4,600 shs

Miscellaneous

Beta
0.90
Creation Unit
50,000
Creation Fee
$850.00
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

Top 10 IDNA Holdings

  • BeOne Medicines Ltd.
    Holding Weight: 6.00%
  • GSK plc
    Holding Weight: 5.68%
  • Exelixis (NASDAQ:EXEL)
    Holding Weight: 5.46%
  • Roche Holding AG
    Holding Weight: 5.30%
  • AstraZeneca PLC
    Holding Weight: 5.13%
  • Genmab A/S
    Holding Weight: 4.91%
  • Takeda Pharmaceutical Company Limited
    Holding Weight: 4.87%
  • SpringWorks Therapeutics (NASDAQ:SWTX)
    Holding Weight: 4.83%
  • Sanofi
    Holding Weight: 4.82%
  • Incyte (NASDAQ:INCY)
    Holding Weight: 4.28%

IDNA Sector Exposure

IDNA Industry Exposure


This page (NYSEARCA:IDNA) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners